Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

144.22 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Earnings Preview For Illumina
Via Benzinga
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements
Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio. 
Via InvestorPlace
Tuesday Talk: A Good Month - Two Days To Go
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the 
Via Talk Markets
3 Stocks to Buy for the Age of Personalized Medicine
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider. 
Via InvestorPlace
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
Analyst Ratings For Illumina
Via Benzinga
Why Illumina Rallied 36.6% in December
The beaten-down gene sequencing company is getting a further shakeup. 
Via The Motley Fool
Jim Cramer: Stay Away From This Major Airline Stock, 'People Should Understand Airlines Are Trades'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended to stay away from Delta Air Lines, Inc. (NYSE: DAL). "People should understand airlines are trades," he noted. 
Via Benzinga
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now. 
Via InvestorPlace
7 Mighty Healthcare Stocks Changing the Game of Medicine
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Biotech Playbook: Small Caps Show Momentum Peaking During
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
Illumina To Sell Grail After U.S. Antitrust Ruling
The $7.1 billion deal has faced major regulatory opposition. 
Via Investor's Business Daily
Analyst Expectations for Illumina's Future
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit
Illumina, Inc. (NASDAQ: ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and  
Via Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit
Illumina, Inc. (NASDAQ: ILMN) announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson (NYSE: JNJ). 
Via Benzinga
Small Caps Are On A Tear Including Speculative Biotechs
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. 
Via Talk Markets
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
Despite a Wednesday tumble, the major indexes are right at 2023 highs. 
Via Investor's Business Daily
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758... 
Via Benzinga
Carl Icahn Escalates Boardroom Battle At Illumina, Seeks To Remove More Directors After Grail Divestiture
Activist investor Carl Icahn said on Monday that he plans to oust legacy conflicted directors at Illumina Inc (NASDAQ: ILMN), laying the groundwork for a second board challenge at the San Diego... 
Via Benzinga
Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years
On Sunday, gene-sequencing company Illumina Inc (NASDAQ: ILMN) agreed to divest cancer diagnostic test maker Grail Inc as the companies battled with the U.S. 
Via Benzinga
Illumina Stock Rises On Plans To Divest Controversial Buyout Grail
Illumina has been in hot regulatory water since the decision to acquire Grail in 2021. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Illumina Analyst Optimistic On Company's Prospects For 'Accelerated Growth'
Illumina, Inc. (NASDAQ: ILMN) has come to loggerheads with EU antitrust regulators related to their investigation into the $7.1 billion acquisitio 
Via Benzinga
Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage
Illumina Inc (NASDAQ: ILMN) reportedly clashed with EU antitrust regulators, alleging an overreach in their investigation into its 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.